ALIMERA SCIENCES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 17 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-07-18: Reporting owner Snisarenko John; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-06-19: Reporting owner Halak Brian K; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-06-19: Reporting owner Kong Garheng; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-06-19: Reporting owner Pizzo Peter J. III; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-07-18 | Snisarenko John Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +46,150 46,150 owned after | $0.87 exercise price | 2019-07-22 | |
| 2019-06-19 | Halak Brian K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.92 exercise price | 2019-06-21 | |
| 2019-06-19 | Kong Garheng Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.92 exercise price | 2019-06-20 | |
| 2019-06-19 | Pizzo Peter J. III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.92 exercise price | 2019-06-20 | |
| 2019-06-19 | Largent James R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.92 exercise price | 2019-06-20 | |
| 2019-06-19 | Myers C. Daniel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.92 exercise price | 2019-06-20 | |
| 2019-06-19 | Szela Mary T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.92 exercise price | 2019-06-20 | |
| 2019-04-12 holding as of filing | Kaba Samer Officer (Chief Medical Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $0.99 exercise price | 2019-04-12 | ||
| 2019-01-23 | Jones John Philip Officer (Chief Financial Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $0.86 exercise price | 2019-01-25 | |
| 2019-01-23 | Holland David Officer (Chief Marketing Officer & SVP) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +170,000 170,000 owned after | $0.86 exercise price | 2019-01-25 | |
| 2019-01-23 | EISWIRTH RICHARD S JR Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 500,000 owned after | $0.86 exercise price | 2019-01-25 | |
| 2019-01-23 | Ashman Philip Officer (Chief Operating Officer & SVP) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.86 exercise price | 2019-01-25 | |
| 2019-01-11 holding as of filing | Jones John Philip Officer (Chief Financial Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $5.00 exercise price | 2019-01-11 | ||
| 2019-01-11 holding as of filing | Jones John Philip Officer (Chief Financial Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $2.36 exercise price | 2019-01-11 | ||
| 2019-01-11 holding as of filing | Jones John Philip Officer (Chief Financial Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $2.00 exercise price | 2019-01-11 | ||
| 2019-01-11 holding as of filing | Jones John Philip Officer (Chief Financial Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $1.49 exercise price | 2019-01-11 | ||
| 2019-01-11 holding as of filing | Jones John Philip Officer (Chief Financial Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $1.30 exercise price | 2019-01-11 |